title: Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin.
abstract: Human recombinant erythropoietin (rHu-Epo) is now extensively used in chronic renal failures; this treatment, resulting in a correction of the severe anemias seen in hemodialysed patients, may in turn lead to a resistance to rHu-Epo therapy by reason of the shortage of erythropoiesis factors, such as iron, vitamin B12 and folates. The utility of the red cell indices (MCV, MCH, RDW) for detection of early iron, folate and B12 deficiencies was studied in eighteen hemodialysed patients with end-stage renal failure treated with rHu-Epo; Microcytosis (MCV < 80 fl) was found ineffective in detecting iron deficiencies as well as macrocytosis (MCV > 100 fl) in folate and B12 deficiencies, partly due to the high incidence of associated iron and folate deficiencies. Lowered MCH (< 27 pg) was not more efficient than microcytosis in detecting early iron deficiencies. Increased RDW was the most sensitive feature for folate, iron and B12 deficiencies with respective sensitivities of 62.5%, 72% and 75%. The global specificity for detecting all deficiencies was 74%. However, high RDW values were not indicative of any type of deficiency; it may thus be concluded that RDW is a non expensive, non invasive and sensitive test, which allows a selection of hemodialysed patients treated with rHu-Epo for a complete investigation program, in order to detect early iron, B12 and folate deficiencies.
authors.affiliation: Laboratoire de Biologie, Hôpital Saint André, Bordeaux, France.
authors.forename: P
authors.initials: P
authors.lastname: Fialon
authors.forename: A G
authors.initials: AG
authors.lastname: Leaute
authors.forename: P
authors.initials: P
authors.lastname: Sassier
authors.forename: C
authors.initials: C
authors.lastname: Vallot
authors.forename: C
authors.initials: C
authors.lastname: Wone
mesh_terms: D000747:Anemia, Hypochromic / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D004351:Drug Resistance; D004909:Erythrocyte Indices; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000032:analysis; D005494:Folic Acid Deficiency / Q000097:blood / Q000175:diagnosis* / Q000209:etiology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*; D017211:Treatment Failure; D014806:Vitamin B 12 Deficiency / Q000097:blood / Q000175:diagnosis* / Q000209:etiology
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin; D005293:Ferritins